These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26774079)

  • 21. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
    Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L
    Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The management of hydatidiform mole with lung nodule: a retrospective analysis in 53 patients.
    Li X; Xu Y; Liu Y; Cheng X; Wang X; Lu W; Xie X
    J Gynecol Oncol; 2019 Mar; 30(2):e16. PubMed ID: 30740949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low risk of relapse after achieving undetectable HCG levels in women with partial molar pregnancy.
    Wolfberg AJ; Growdon WB; Feltmate CM; Goldstein DP; Genest DR; Chinchilla ME; Berkowitz RS; Lieberman ES
    Obstet Gynecol; 2006 Aug; 108(2):393-6. PubMed ID: 16880311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
    Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pre-evacuation hCG glycoforms in uneventful complete hydatidiform mole and persistent trophoblastic disease.
    Thomas CM; Kerkmeijer LG; Ariaens HJ; van der Steen RC; Massuger LF; Sweep FC
    Gynecol Oncol; 2010 Apr; 117(1):47-52. PubMed ID: 20116088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of 5-day MTX and 5-day ETP treatment results and early predictors of drug resistance to 5-day MTX in patients with post-molar low-risk gestational trophoblastic neoplasia.
    Kizaki S; Hashimoto K; Matsui H; Usui H; Shozu M
    Gynecol Oncol; 2015 Dec; 139(3):429-32. PubMed ID: 26456138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural history of hydatidiform mole after primary evacuation.
    Lurain JR; Brewer JI; Torok EE; Halpern B
    Am J Obstet Gynecol; 1983 Mar; 145(5):591-5. PubMed ID: 6829636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive value of B-human chorionic gonadotropin for progression of molar pregnancy to persistent gestational trophoblastic neoplasm.
    Yarandi F; Mohseni M; Alikhasi M; Ramhormozian S; Shirali E
    Minerva Obstet Gynecol; 2023 Jun; 75(3):205-212. PubMed ID: 34498836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of patients with persistent trophoblastic disease after complete hydatidiform mole by using a normal 24-hour urine hCG regression curve.
    van Cromvoirt SM; Thomas CM; Quinn MA; McNally OM; Bekkers RL
    Gynecol Oncol; 2014 Jun; 133(3):542-5. PubMed ID: 24631700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of persistent gestational trophobalstic neoplasia: the role of hCG level and ratio in 2 weeks after evacuation of complete mole.
    Kang WD; Choi HS; Kim SM
    Gynecol Oncol; 2012 Feb; 124(2):250-3. PubMed ID: 22094931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management and outcome of healthy women with a persistently elevated beta-hCG.
    Palmieri C; Dhillon T; Fisher RA; Young AM; Short D; Mitchell H; Aghajanian C; Savage PM; Newlands ES; Hancock BW; Seckl MJ
    Gynecol Oncol; 2007 Jul; 106(1):35-43. PubMed ID: 17482245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic characteristics of serum human chorionic gonadotropin titer regression following molar pregnancy.
    Schlaerth JB; Morrow CP; Kletzky OA; Nalick RH; D'Ablaing GA
    Obstet Gynecol; 1981 Oct; 58(4):478-82. PubMed ID: 7279342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Follow-Up After Molar Pregnancy Evacuation: Feasibility of Using Semi-Quantitative Urine Pregnancy Tests.
    Hoppenot C; Zimmerman L; Arlandson M; Lurain JR; Patel A
    J Reprod Med; 2016; 61(5-6):192-6. PubMed ID: 27424357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gestational trophoblastic disease: is intensive follow up essential in all women?
    Pisal N; Tidy J; Hancock B
    BJOG; 2004 Dec; 111(12):1449-51. PubMed ID: 15663134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia among women with partial molar pregnancies.
    Growdon WB; Wolfberg AJ; Feltmate CM; Goldstein DP; Genest DR; Chinchilla ME; Berkowitz RS; Lieberman ES
    J Reprod Med; 2006 Nov; 51(11):871-4. PubMed ID: 17165432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early detection of persistent trophoblastic tumour by serum human chorionic gonadotrophin monitoring after molar pregnancy.
    Ngan HY; Wong LC
    Chin Med J (Engl); 1999 Mar; 112(3):260-3. PubMed ID: 11593563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Normal human chorionic gonadotropin regression curves in uneventful postmolar patients.
    Kizaki S; Matsui H; Usui H; Shozu M; Hanawa S; Yamamoto E; Kikkawa F
    J Reprod Med; 2012; 57(5-6):243-8. PubMed ID: 22696820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human Chorionic Gonadotropin Regression Curves after Partial or Complete Molar Pregnancy in Flanders: Are They Different from Regression Curves from the Eighties?
    Delattre S; Han S; Moerman P; Billen J; Goffin F; Scharpé K; Vergote I
    Gynecol Obstet Invest; 2018; 83(1):76-82. PubMed ID: 28329740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of gestational trophoblastic neoplasia after hCG normalisation according to hydatidiform mole type.
    Schmitt C; Doret M; Massardier J; Hajri T; Schott AM; Raudrant D; Golfier F
    Gynecol Oncol; 2013 Jul; 130(1):86-9. PubMed ID: 23523617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human chorionic gonadotropin follow-up in patients with molar pregnancy: a time for reevaluation.
    Feltmate CM; Batorfi J; Fulop V; Goldstein DP; Doszpod J; Berkowitz RS
    Obstet Gynecol; 2003 Apr; 101(4):732-6. PubMed ID: 12681878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.